Skip to main content
. 2022 Sep 18;13(3):446–460. doi: 10.34172/apb.2023.056

Table 3. Drug Delivery through Nasal route by NLC .

Drug Purpose Solid lipid Liquid lipid Surfactant Formulation method Outcome Ref.
Almotriptan malate Nasal delivery of antimigraine drug Compritol Labrafil Tween 80 and lauroglycol Hot homogenization and ultrasonication technique In sheep nasal mucosa, chitosan-coated NLC showed enhanced mucoadhesion and high drug permeability, in vivo study shows high Cmax than the solution and oral marketed formulation in albino rabbits 72
Lorazepam Nasal delivery of drug for status epilepticus Glyceryl monostearate Oleic acid Tween 80 and pluronic F127 Solvent diffusion and evaporation method Chitosan-based NLC show a sustained in vitro drug release rate as well as better in vivo result in convulsion model rats. 73
Mosapride citrate Nasal delivery of prokinetic agent for GERD Stearic acid isopropyl myristate L-alpha lecithin and Lutrol F127 Melt–emulsification low temperature–solidification technique Drug loaded NLC show 3-fold increase in drug permeation in sheep nasal mucosa and increased gastric emptying rate and bioavailability in comparison to a drug suspension and marketed oral preparation. 74
Oleuropein Phytochemical loaded NLC for treatment of meningitis Tefose Capmul Poloxamer 188, polysorbate 80, and soy lecithin Melt emulsification and ultrasonication method High permeation of drugs is seen in the nasal mucosa. Initial burst release followed by sustained release is shown in in vitro studies. 31
Carbamazepine For fast action of anti-epileptic drug through nose-to-brain targeting Precirol ATO 5 Capmul MCM Tween 80 and span 20 Microemulsion technique followed by probe sonication Thermosensitive in situ gel using poloxamer 407 (P407), poloxamer 188 (P188), and the mucoadhesive polymer were used. NLC-based gel exhibits greater drug diffusion in sheep nasal mucosa and anticonvulsant activity in MES model rats than non-NLC-based gel and drug dispersion. 75
Flibanserin Nose-to-brain delivery of seratonergic agent Glyceryl behenate Sweet almond oil L-phosphatidyl choline and gelucire 44/14 High speed homogenization followed by sonication Optimized formulation shows better drug release. In vivo assessment shows high plasma and brain drug concentration than raw drug. 76
Escitalopram and Paroxetine Nose to brain drug delivery for treatment of depression Precirol ATO 5 Lauroglycol 90 Tween 80 High Pressure Homogenization Technique In vivo assays of NLC shows similar systemic drug with respect to i.v. drug administration. Borneal encapsulation result in five-time greater brain drug concentration with less systemic exposure. 77